NOUNGUIM CALDERON: Open Payments
NPI 1497420129 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 5 payments from 5 companies in 2025. Trend: 2023 $42 · 2024 $226 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: CAPVAXIVE, MOUNJARO, Ozempic, AREXVY, LifeVest.
Industry payments across MD — which companies pay providers there.
